ProfileGDS4718 / 1558604_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 48% 74% 53% 50% 45% 45% 52% 55% 53% 48% 47% 49% 50% 50% 51% 53% 47% 46% 40% 54% 54% 48% 48% 50% 50% 52% 49% 50% 45% 51% 52% 53% 51% 46% 45% 46% 50% 55% 70% 51% 46% 50% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4515849
GSM549102patient 115, normal, homogenized [OPG study]5.4470248
GSM549104patient 119, normal, homogenized [OPG study]7.2912674
GSM549108patient 138, normal, homogenized [OPG study]5.7326453
GSM549119patient 077, normal, homogenized [OPG study]5.520150
GSM549133patient 032, cancer, homogenized [OPG study]5.1716945
GSM549139patient 042, cancer, homogenized [OPG study]5.2094945
GSM549099patient 107, normal, homogenized [OPG study]5.6460252
GSM549109patient 139, normal, homogenized [OPG study]5.8090755
GSM549110patient 046, normal, homogenized [OPG study]5.690753
GSM549114patient 063, normal, homogenized [OPG study]5.3325348
GSM549122patient 082, normal, homogenized [OPG study]5.3682547
GSM549134patient 033, cancer, homogenized [OPG study]5.4201449
GSM549136patient 036, cancer, homogenized [OPG study]5.4373750
GSM549140patient 044, cancer, homogenized [OPG study]5.4983350
GSM549111patient 047, normal, homogenized [OPG study]5.5486251
GSM549113patient 057, normal, homogenized [OPG study]5.6174953
GSM549132patient 031, cancer, homogenized [OPG study]5.3522447
GSM549137patient 038, cancer, homogenized [OPG study]5.2531646
GSM549142patient 047, cancer, homogenized [OPG study]5.1303540
GSM549100patient 110, normal, homogenized [OPG study]5.7239854
GSM549107patient 135, normal, homogenized [OPG study]5.7458654
GSM549115patient 068, normal, homogenized [OPG study]5.3457148
GSM549116patient 072, normal, homogenized [OPG study]5.3770748
GSM549120patient 078, normal, homogenized [OPG study]5.4831650
GSM549131patient 030, cancer, homogenized [OPG study]5.4641650
GSM549118patient 074, normal, homogenized [OPG study]5.6276952
GSM549129patient 027, cancer, homogenized [OPG study]5.4658549
GSM549123patient 088, normal, homogenized [OPG study]5.5231950
GSM549124patient 006, cancer, homogenized [OPG study]5.275345
GSM549126patient 015, cancer, homogenized [OPG study]5.5525551
GSM549128patient 025, cancer, homogenized [OPG study]5.5990152
GSM549103patient 117, normal, homogenized [OPG study]5.7112153
GSM549117patient 073, normal, homogenized [OPG study]5.4957751
GSM549138patient 041, cancer, homogenized [OPG study]5.2556146
GSM549141patient 045, cancer, homogenized [OPG study]5.1893145
GSM549130patient 028, cancer, homogenized [OPG study]5.3184846
GSM549101patient 111, normal, homogenized [OPG study]5.5406950
GSM549105patient 128, normal, homogenized [OPG study]5.8346855
GSM549106patient 134, normal, homogenized [OPG study]6.9476770
GSM549112patient 048, normal, homogenized [OPG study]5.584251
GSM549125patient 011, cancer, homogenized [OPG study]5.2939446
GSM549127patient 024, cancer, homogenized [OPG study]5.5361750
GSM549135patient 035, cancer, homogenized [OPG study]5.4377949